Goldman Sachs’s MDxHealth MDXH Stock Holding History

Goldman Sachs’s Portfolio MDXH Stock Details MDXH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-98,619	Closed	-$227K	–	6833
2026 Q1	$227K	Buy	98,619 +14,217	+17%	+$48.3K	﹤0.01%	6024
2025 Q4	$301K	Buy	+84,402	New	+$333K	﹤0.01%	5864

Other funds holding MDXH

Bleichroeder LP New York $559M AUM 83.7% 1-Year Est. Return

MVM Partners Boston, Massachusetts $1.91M AUM 81.42% 1-Year Est. Return

PCM

Perkins Capital Management Wayzata, Minnesota $133M AUM 127.86% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

GCP

GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Squarepoint New York $90.5B AUM 33.95% 1-Year Est. Return

XTX Topco George Town, Cayman Islands $7.72B AUM 32.88% 1-Year Est. Return

Goldman Sachs's MDXH Position: Q2 2026 in Review

Goldman Sachs sold out of MDxHealth (MDXH) in Q2 2026, closing a stake of 98,619 shares — an estimated $227K sold.

Goldman Sachs first reported a position in MDXH in Q4 2025 and held it in 2 quarters. The position peaked at $301K in Q4 2025. 26 funds tracked by Wall St. Rank hold MDXH as of Q2 2026.

Goldman Sachs reported no remaining MDxHealth position as of Q2 2026 after selling out during the quarter.
Goldman Sachs sold 98,619 MDxHealth shares in Q2 2026, an estimated $227K.
Goldman Sachs first reported a position in MDxHealth in Q4 2025 and held it in 2 quarters.
Goldman Sachs's MDxHealth position peaked at $301K in Q4 2025.
26 funds tracked by Wall St. Rank held MDxHealth as of Q2 2026.

Based on Goldman Sachs's 13F filing for Q2 2026, filed 14 Aug 2026.